Fulminant viral hepatitis in Kuwait.

Area of Science:

• Hepatology
• Virology
• Clinical Medicine

Background:

• Fulminant viral hepatitis is a rare but severe liver disease.
• Understanding the etiological agents and clinical course is crucial for patient management.

Purpose of the Study:

• To investigate the causes and clinical outcomes of fulminant viral hepatitis in a cohort of 34 patients.
• To identify demographic patterns associated with specific viral etiologies.

Main Methods:

• Retrospective analysis of 34 patients diagnosed with fulminant viral hepatitis.
• Serological testing to determine the causative viral agents: Hepatitis B virus (HBV), non-A, non-B (NANB) viruses, Hepatitis A virus (HAV), and delta agent.
• Clinical data review including patient demographics and outcomes.

Main Results:

• Hepatitis B virus (HBV) was identified in 47% of cases, and non-A, non-B (NANB) viruses in 38%.
• Hepatitis A virus (HAV) and delta agent superinfection accounted for 9% and 6% of cases, respectively.
• The majority of patients (47%) were aged 21-40 years. HAV-related fulminant hepatitis occurred in children under five, while delta infections were seen in patients over 40.
• Fulminant hepatitis was fatal in all but one NANB case, irrespective of gender.

Conclusions:

• Hepatitis B virus and NANB viruses are the predominant causes of fulminant viral hepatitis.
• Age is a significant factor in the etiology of fulminant hepatitis, with distinct patterns for HAV and delta infections.
• Fulminant viral hepatitis carries a grave prognosis, with near-universal mortality observed in this study.